HEALWELL AI is a healthcare technology company focused on AI and data science for preventative care.
Our mission is to improve healthcare and save lives through early identification and detection of disease. As a physician-led organization with a proven management team of experienced executives, HEALWELL AI is executing a strategy centered around developing and acquiring technology and clinical sciences capabilities that complement the company’s roadmap.
AI-Enabled Decision Support For Healthcare Providers
Identify
Identify the gap in care and how AI can advance current standards.
Build
Build a disease specific risk screening criteria logic/code algorithm.
Predict
Predict and diagnose disease faster than clinicians with minimal error.
Train
Train clinical teams.
Launch
Launch primary care and/or a specialty offering segment.
Accelerate
Accelerate early diagnosis and linkage to care options.
Curbing Healthcare Costs, Supporting Doctors &
Improving Patient Outcomes
Exclusive Strategic
Partnership
& Lead Investor
#1
DIGITAL HEALTH ECOSYSTEM IN CANADA
WELL’s apps.health is Canada’s leading EMR App Ecosystem providing extensive tech enablement for care providers nationally
5M+
YEARLY PATIENT VISITS & INTERACTIONS
The largest owned and operated healthcare ecosystem in Canada and significant operations across the United States
30,000+
HEALTHCARE PROVIDERS TECH ENABLED
More than one out of every 4 doctors in Canada rely on WELL digital solutions to drive their patient services business
>$1Bn
IN M&A
Across more than 60 transactions in the clinical and digital space
Exclusive Strategic Partnership
& Lead Investor
4M+
ANNUAL PATIENT VISITS
The largest owned & operated
healthcare ecosystem in Canada
30,000+
HEALTHCARE PROVIDERS
Enabled by WELL solutions
across Canada and the U.S.
>$1.3Bn
IN M&A
Across more than 60 transactions
Products and Services
Khure Health
Khure Health is a wholly owned subsidiary of HEALWELL AI. Khure is an AI health technology company whose precision medicine platform harnesses clinical data, enabling physicians to rapidly screen and identify patients with rare diseases and facilitate more personalized treatment. Khure is actively working with and/or has rare and specialty disease programs in development with 7 of the top 10 Pharma
companies and international disease associations.
Pentavere
HEALWELL AI is a majority shareholder of Pentavere Research Group, a globally recognized and award-winning AI digital health company that has built a best-in-class AI engine to identify patients that are eligible for approved medications or interventions, to improve outcomes for patients and help drive
therapy growth and penetration. Over the past several years, Pentavere has published an impressive array of literature in high-impact, peer-reviewed medical journals, totalling more than 30 manuscripts, which serve as a testament to Pentavere’s capabilities and adds significant credibility to their
technology.
Intrahealth
Intrahealth is a pioneering force in healthcare technology, specializing in the development and implementation of state-of-the-art EMR or HER solutions. With a relentless commitment to advancing patient care, Intrahealth empowers healthcare providers, institutions, and governments with innovative digital tools designed to enhance healthcare delivery and improve patient outcomes.
WELL AI Decision Support
Developed in partnership with WELL Health Technologies Corp., HEALWELL AI provides ‘WELL AI Decision Support’, a groundbreaking solution that leverages AI technologies to enable the earlier diagnosis, treatment and improved quality of life for the patient. WELL AI Decision Support enables healthcare providers to accurately identify over 110 complex or rare diseases often overlooked by traditional methods, providing hope to thousands of patients across Canada.
PolyClinic
HEALWELL AI Polyclinic provides onsite integrated health services including primary care, specialist care, lab services, and an in-house clinical research organization. With integrated systems and data-driven tools, HEALWELL AI Polyclinic plans to unlock meaningful insights from consistent, high-quality, structured clinical information from over 50 primary care physicians and specialists, labs, and clinical
trials.
BioPharma Services
BioPharma Services is a leading contract research organization (CRO) based in Toronto, Canada, specializing in Phase 1 and Phase 2a clinical trials. With a focus on scientific integrity, operational excellence, and adaptive processes tailored to each client’s needs, BioPharma Services has established a reputation for delivering high-quality results in the pharmaceutical and biotech industries. BioPharma’s comprehensive services also include Bioanalysis at their GLP Certified Laboratory, Scientific and Regulatory Affairs, Biostatistics and Safety Data Analysis (CDISC), Data Management and Medical Writing.
VeroSource Solutions
VeroSource Solutions is a digital health company established in 2014 to empower people and unlock the potential in Canadian healthcare. Its team of professionals has extensive experience in the full lifecycle of healthcare IT solutions and offers healthcare providers the technology and support needed to go digital. VeroSource’s cloud-first multi-channel software securely connects people, data and systems to drive digital healthcare transformation. Founded in Fredericton, NB, VeroSource has grown to include team members across Ontario and the Atlantic Canadian provinces.
Mutuo Health Solutions
Mutuo Health Solutions is a Toronto-based medical artificial intelligence company focused on developing predictive clinical AI technology. Their flagship product, AutoScribe, is an advanced AI-powered ambient scribe solution that transcribes clinician-patient interactions into high-quality electronic medical records in real time. AutoScribe utilizes natural language processing and machine learning technology to accurately capture and structure patient data, enabling healthcare providers to focus on patient care and improve clinical efficiency.